ARCHIVE

• Imiquimod, Garenoxacin Recommended for Approval
  June 11, 2007

• Chuikyo Starts Discussing FY2008 Drug Pricing Reform
  June 11, 2007

• Combined Sales, Profits of 4 Major Generic Firms Show Double-Digit Increases
  June 11, 2007

• Taiyo Yakuhin: Sales Up but Ordinary Profits Down due to Aggressive Investment
  June 11, 2007

• Towa: Operating Profits Up 84% as a Result of "Reasonable Pricing Policy"
  June 11, 2007

• Suzuken Launches Given Imaging's Capsule Endoscope
  June 11, 2007

• Sawai: Investment for Future Growth Cuts Profits Despite 28.9% Rise in Sales
  June 11, 2007

• Given Imaging's Capsule Endoscope Spotlighted at JGES Meeting
  June 11, 2007

• Trade-Off Concept Should Underlie New Pricing System: Dr Aoki
  June 11, 2007

• MEDICAL DEVICE NEWS IN BRIEF
  June 11, 2007

• Lack of Experienced CRAs Decelerates Growth of CRO Business: Mr Nakamura of CMIC
  June 11, 2007

• Japan-Specific GCP Requirements Must Be Eliminated: SJP Seminar
  June 11, 2007

• EPS to Aggressively Hire New Graduates
  June 11, 2007

• R&D NEWS IN BRIEF
  June 11, 2007

• Early Price Offering by Wholesalers Essential to Expedite Price Negotiation Process: Korosho
  June 11, 2007

• REPORTER'S EYE／Incidence of NSAID-Induced Ulcers on the Rise in Japan
  June 11, 2007

• Korosho Should Also Listen to Small Pharmacy Chains: Mr Kashiwagi
  June 11, 2007

• Time to Launching of Anticancer Agents to Be Shortened by 2.5 Years: Korosho Council
  June 11, 2007

• Further Efforts Needed to Improve Business Practices: Mr Matsutani
  June 11, 2007

• SURVEY／Arrhythmia, Heart Disease Recognized as Risk Factors of Stroke by Only 40% of Japanese
  June 11, 2007

ページ

• « 先頭
• ‹ Prev
• …
• 336
• 337
• 338
• 339
• 340
• 341
• 342
• 343
• 344
• …
• Next ›
• 最終 »